نتایج جستجو برای: stem cell therapy

تعداد نتایج: 2324998  

عبدانی پور, علیرضا, منصوری, مژده, نیکفر, علی,

Background and purpose: The use of an appropriate stimulus for increasing the rate of neural stem cell proliferation is one of the most important issues in cell therapy. This study aimed to investigate the effect of hydroethanolic extract of Stachys byzantina on hippocampus-derived neural stem cell proliferation and apoptosis. Materials and methods: In this experimental study, the neural ste...

Ali Gholamrezanezhad, Ardeshir Ghavamzadeh Davood Beiki, Jalil Majd Ardekani Kamran Alimoghadam Kianoush Ansari Gilani Maryam Bashtar Mehdi Mohammadnezhad Mohammad Bagheri Mohsen Saghari Reza Malekzadeh Sahar Mirpour,

  Introduction: The field of stem cell biology and regenerative medicine is rapidly moving toward translation to clinical practice. Stem cell therapy seems to be a new treatment option for some diseases. So, tracking the distribution of stem cells is crucial to their therapeutic use. Based on this fact we labeled human mesenchymal stem cells (MSCs) with 111...

Journal: :cell journal 0

stem cell therapy is a powerful technique for the treatment of a number of diseases. stem cells are derived from different tissue sources, the most important of which are the bone marrow (bm), umbilical cord (uc) blood and liver. human uc mesenchymal stem cells (huc-mscs) are multipotent, non-hematopoietic stem cells that have the ability to self-renew and differentiate into other cells and tis...

Sajad Sahab Negah, Sanaz Sheykhian,

Multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE), are chronic inflammatory demyelinating disorders of central nervous system (CNS). While the cause is unclear, the fundamental mechanism is thought to be destruction of myelin sheaths of neurons through immune system. One of the approaches being proposed in EAE therapy is neural stem cells (NSCs) trans...

Neurogenic bladder (NGB) secondary to spinal cord injury (SCI) is accompanied with several complications such as urinary tract deterioration, urinary incontinence, and consequently lower quality of life (QoL), significant morbidities, and occasionally death. Current therapeutic methods have some side effects and there is no treatment for the upper urinary tract injuries. Stem cell therapy is a ...

Hajar Shafaei, Hojjat Ollah Nozad, Jafar Soleimani Rad, Khadijeh Dizaji Asl,

BACKGROUND Mesenchymal stem cells (MSCs) are ideal candidates for treatment of diseases. Amniotic membranes are an inexpensive source of MSCs (AM-MSC) without any donor site morbidity in cell therapy. Adipose tissue derived stem cells (ASCs) are also suitable cells for cell therapy. There is discrepancy in CD271 expression among MSCs from different sources. In this study, the characteristics...

Abdolamir Allameh

Liver failure, in an acute or chronic form, is a growing health problem ranking as one of the leading causes of death worldwide. Inborn errors of metabolism characterized by defects in hepatic enzymes or other proteins with metabolic functions, such as receptors or transporters accompanied with environmental factors involve etiology and presentation of liver failure. Currently, the only establi...

Journal: :international journal of hematology-oncology and stem cell research 0
ardeshir ghavamzadeh hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, shariati hospital, tehran, iran kamran alimoghaddam hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, shariati hospital, tehran, iran mohammad jahani hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, shariati hospital, tehran, iran seyed asad-o-allah mousavi hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, shariati hospital, tehran, iran masoud iravani hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, shariati hospital, tehran, iran babak bahar hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, shariati hospital, tehran, iran

hematology- oncology and stem cell transplantation research center related to tehran university of medical sciences located in shariati hospital. these center activities have started in 1991 in order to help needful patients and augment new data to reach new aspects of therapeutic trials. also it is one of the greatest stem cell transplantation centers in world and is the second center in the w...

Objective(s): In the past few decades, variety of foetal, embryonic and adult stem and progenitor cells have been tried with conflicting outcome for cell therapy of central nervous system injury and diseases. Cellular characteristics and functional plasticity of Globose basal stem cells (GBCs) residing in the olfactory epithelium of rat olfactory mucosa have not been studied in the past by the ...

Journal: :iranian red crescent medical journal 0
ardeshir ghavamzadeh hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, ir iran kamran alimoghaddam hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, ir iran; hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, ir iran. email: fatemeh ghaffari hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, ir iran roshanak derakhshandeh hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, ir iran arash jalali hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, ir iran mohammad jahani hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, ir iran

conclusions in iran, hsct has been successfully adapted in routine clinical care. recently, new methods such as double cord blood and haploidentical transplantation have been used to treat many life-threatening diseases. results about 78.2% of the patients (2530 of 3237) remained alive between one to 211 months after stem cell transplantation. nearly, 21.8% (707) of our patients died after stem...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید